Oral eosinophilic granuloma is a component of the feline eosinophilic granuloma complex, a group of inflammatory skin and oral conditions characterized by the abnormal accumulation of eosinophils, a type of white blood cell involved in allergic and inflammatory responses. When affecting the oral cavity, these lesions can appear on the lips, gums, tongue, palate, and pharynx, causing raised, firm, often ulcerated masses that can significantly impact eating and quality of life. The condition is relatively common in cats, affecting animals of all ages but with increased prevalence in young adult cats. The lesions have a distinctive appearance and are often diagnosed presumptively based on clinical presentation, though biopsy provides definitive confirmation.
The underlying cause of eosinophilic granuloma is believed to involve dysregulated immune responses, often triggered by allergic reactions to environmental allergens, food allergens, or insect bites including fleas and mosquitoes. The exact mechanism by which these triggers cause the characteristic eosinophilic inflammation remains incompletely understood, but the condition is generally considered part of the spectrum of allergic disease in cats. Genetic predisposition appears to play a significant role, with certain family lines showing increased susceptibility. The immune system abnormally recruits eosinophils to affected tissues, where they release inflammatory mediators and cause tissue damage that produces the characteristic lesions.
The impact of oral eosinophilic granuloma on affected cats ranges from mild cosmetic concerns to severe debilitation depending on lesion location, size, and number. Small lesions may cause no apparent discomfort, while large lesions affecting the tongue or pharynx can significantly impair eating and swallowing. Lip lesions, often called rodent ulcers, can become quite large and disfiguring. Pain associated with oral lesions may cause decreased appetite, weight loss, and behavioral changes. The chronic, relapsing nature of the condition can be frustrating for owners and may require ongoing management to maintain quality of life. Secondary bacterial infection of ulcerated lesions can exacerbate clinical signs.
Treatment for oral eosinophilic granuloma focuses on reducing inflammation through immunomodulatory therapy and, when possible, identifying and eliminating underlying allergic triggers. Corticosteroids remain the mainstay of treatment, typically producing rapid improvement in most cases. However, recurrence is common when treatment is discontinued or when the underlying allergic trigger cannot be identified and removed. Long-term management may require ongoing or intermittent therapy to control signs. Identification of allergic triggers through elimination diets, flea control, or allergy testing can enable more targeted prevention. With appropriate management, most cats with oral eosinophilic granuloma achieve good quality of life, though the condition often requires lifelong attention.
